World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Uncategorized

Statement from Dr. Larry Schlesinger, President & CEO, Texas Biomedical Research Institute

Cision PR Newswire by Cision PR Newswire
January 23, 2026
in Uncategorized
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

SAN ANTONIO, Jan. 23, 2026 /PRNewswire/ — In response to today’s news over whether long‑standing vaccine recommendations remain necessary, I want to publicly stress strong support for science‑based immunization schedules and the incredible role vaccines have played in saving lives worldwide.


Texas Biomedical Research Institute Logo

The scientific evidence is clear. Established vaccine schedules remain one of the most powerful and effective public health tools ever developed. Vaccines have transformed human health for more than a century. Since the introduction of routine childhood immunizations in 1974, millions of lives have been saved worldwide.

We forget how dangerous childhood once was. Vaccines didn’t just reduce disease; they completely rewrote what childhood looks like. An estimated 154 million children who might otherwise have died before age five are alive today, including nearly 94 million lives saved through measles vaccination alone.

Life expectancy increased dramatically in the 20th century, rising from roughly 47 years in 1900 to nearly 77 years by 2000 in the U.S. This was largely due to a massive decline in infant and child mortality, our national vaccine programs, improved sanitation, antibiotics and advancements in treating chronic diseases.

When people note that many diseases are rare nowadays, they’re right, but that’s because of vaccines. That is the quiet success of public health.

Consider: Polio vaccines have prevented more than 20 million cases of paralysis, and COVID‑19 vaccines averted approximately 20 million deaths in their first year of use.

These outcomes are detailed in Texas Biomed’s Understanding Vaccines guide, which explains how vaccines prepare the immune system to recognize and stop disease before serious illness occurs.

At Texas Biomedical Research Institute (Texas Biomed), scientists conduct rigorous research to advance therapeutics, vaccines and other medical countermeasures against infectious diseases that continue to threaten global health. Our Institute’s 85-year historic work is grounded in decades of immunology, epidemiology and real‑world data demonstrating the safety and effectiveness of vaccines.

About Dr. Schlesinger

Larry S. Schlesinger, MD, is an internationally recognized authority in infectious diseases with a particular interest in tuberculosis and lung biology. TB is the deadliest infectious disease in the world.

About Texas Biomedical Research Institute

Texas Biomedical Research Institute is a nonprofit research institute dedicated to protecting the global community from infectious diseases. Through basic research, preclinical testing and innovative partnerships, we accelerate development of diagnostics, therapies and vaccines for the world’s deadliest pathogens, including the first COVID-19 vaccine, the first Ebola treatment and first Hepatitis C therapy. We are passionate about educating the next generation of bioscience leaders and ensuring a healthier future for all.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/statement-from-dr-larry-schlesinger-president–ceo-texas-biomedical-research-institute-302669230.html

SOURCE Texas Biomedical Research Institute

Cision PR Newswire

Cision PR Newswire

Related Posts

love around the world cultures

Love Around the World: How Different Cultures Define Romance

March 17, 2026
Oscars 2026 fashion

The Best Oscars 2026 Red Carpet Fashion Moments That Defined the Night

March 16, 2026
eating disorders

Eating Disorders in Women: What Is Really Going On and Where to Get Help

March 16, 2026
Mels Robins skin care

The Dermatologist Skincare Routine That Actually Works

March 16, 2026

Ulike Spring: Dare to Glow — Celebrating Confident and Aspirational Women

March 9, 2026

Wilentz, Goldman & Spitzer, P.A. Welcomes Former Presiding Judge Robert J. Mega to the Firm

March 9, 2026

Popular News

  • Artmarket.com: The Artprice Manifesto: 22 Rules for a Regulated and Transparent Art Market in the Age of AI

    0 shares
    Share 0 Tweet 0
  • Switzerland Ranks No. 1 in Revamped 2026 U.S. News Best Countries Report

    0 shares
    Share 0 Tweet 0
  • Robo.ai Subsidiary Neurovia AI Launches NeuroStream™ Technology Platform to Build Physical AI Visual Data Infrastructure

    0 shares
    Share 0 Tweet 0
  • Robbins LLP Urges POET Stockholders Who Lost Money Investing in POET Technologies, Inc. to Contact the Firm for Information About Leading the Class Action

    0 shares
    Share 0 Tweet 0
  • SKE Showcases Flagship Vaping Innovations at Vaper Expo UK

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler